SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following an earnings report that highlighted a significant shift to becoming a net buyer of equities, breaking a long streak of cash accumulation and stock sales. The community is actively debating the company's capital allocation strategy, the effectiveness of new leadership in managing its record-breaking cash reserves, and the stock's role as a potential hedge against broader market volatility.

Cash Cat

Cash Cat is gaining significant attention following its listing on Robinhood, with the community actively debating whether it will emerge as a dominant leader in the memecoin space. Discussions center on potential accumulation strategies and comparisons to other high-profile meme assets, reflecting a mix of bullish optimism and skepticism regarding the coin's long-term sustainability.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is drawing significant attention following the launch of a Klarna-backed leasing program with Apple and a major antitrust legal victory against Google, sparking community debate over its long-term potential as a financial super app. While some investors view the stock as a heavily undervalued opportunity ripe for a breakout, others remain cautious, citing persistent share price volatility and the ongoing impact of macroeconomic pressures on consumer debt and fintech valuations.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors digest unprecedented Phase 3 data for daraxonrasib in pancreatic cancer, with the community actively speculating on a potential Big Pharma acquisition or rapid FDA approval. Discussions center on the drug's survival benefits as a sector-leading breakthrough, with many comparing its market potential to previous high-value biotech exits.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing renewed community focus following strong second-quarter earnings, a raised revenue outlook, and significant insider buying that has analysts and retail traders debating its value as a long-term comeback play. Investors remain actively divided, with many weighing the companys dividend-heavy appeal and oncology pipeline against concerns over stagnant price action and potential patent cliff pressures.

Berkshire Hathaway Inc. - Ordinary Shares - Class A

Berkshire Hathaway is trending following reports of a significant new stake in Alphabet, sparking discussion about whether the conglomerate is pivoting toward AI-driven tech investments. The community is actively debating the move's timing, the firm's evolving capital allocation strategy under new leadership, and whether the purchase signals a long-term shift in Berkshire's traditional value-investing approach.

Symbotic, Inc. is an automation technology company, which engages in a robotics and automation-based product movement technology platform. It focuses on developing, commercializing, and deploying innovative, end-to-end technology solutions for supply chain operations. It operates through the United States and Canada geographical segments. The company was founded by Richard B. Cohen on December 11, 2020 and is headquartered in Wilmington, MA.

Symbotic Inc - Ordinary Shares - Class A

Symbotic Inc 

Symbotic is trending as investors closely monitor its upcoming earnings report, with community sentiment divided between those betting on its long-term warehouse automation dominance and others concerned about high valuation multiples and execution speed. Discussion is heavily focused on the company's massive multi-billion dollar backlog and the role of its AI-driven robotics as a key infrastructure play in the broader industrial automation sector.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as investors aggressively rotate into optical and photonics infrastructure stocks, driven by sustained AI capacity constraints and renewed supply chain security concerns. The community is actively discussing the sector's role as a critical 'bottleneck' in AI hardware, with high conviction surrounding Coherent's massive order backlog and strategic partnerships with major hyperscalers.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Communication Systems, Integrated Mission Systems, Space and Airborne Systems, and Aerojet Rocketdyne. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land, and sea domains. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne, and cyber domains. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

L3Harris Technologies is trending following the announcement of a proposed partnership with the Department of War that includes a significant investment to expand missile production capacity and plans for a future spinoff IPO of its Missile Solutions unit. The community is actively discussing the long-term growth implications of this deal, while also monitoring defense sector momentum and recent contract wins that bolster the firm's backlog.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest as the community eagerly anticipates upcoming clinical data, particularly a podium presentation featuring combination therapy results with Keytruda. Supporters are bullish on the company's platform potential to transform oncology treatment standards, leading to active discussions about its long-term clinical pipeline and the impact of these pending catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


uy88net

UY88 Net